Variant report
Variant | rs9882957 |
---|---|
Chromosome Location | chr3:138599529-138599530 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:138581227..138583620-chr3:138597045..138599792,3 | K562 | blood: | |
2 | chr3:138581629..138583620-chr3:138597045..138599792,2 | K562 | blood: | |
3 | chr3:138593490..138596609-chr3:138597250..138600269,4 | K562 | blood: | |
4 | chr3:138553797..138555960-chr3:138598138..138600170,2 | K562 | blood: |
No data |
No data |
No data |
No data |
rs_ID | r2[population] |
---|---|
rs10804659 | 0.83[EUR][1000 genomes] |
rs11706016 | 0.89[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.91[GIH][hapmap];1.00[JPT][hapmap];0.90[MEX][hapmap];0.91[TSI][hapmap];0.86[EUR][1000 genomes] |
rs11706291 | 0.93[AMR][1000 genomes];0.94[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs11708762 | 0.85[CEU][hapmap];0.83[EUR][1000 genomes] |
rs11716946 | 0.84[EUR][1000 genomes] |
rs11720178 | 0.81[CEU][hapmap];0.80[MEX][hapmap] |
rs12497815 | 0.82[EUR][1000 genomes] |
rs12631035 | 0.85[CEU][hapmap];0.90[MEX][hapmap];0.82[TSI][hapmap];0.83[EUR][1000 genomes] |
rs12633714 | 0.85[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.86[EUR][1000 genomes] |
rs13061496 | 0.89[CEU][hapmap];1.00[CHB][hapmap];1.00[CHD][hapmap];0.86[GIH][hapmap];1.00[JPT][hapmap];0.90[MEX][hapmap];0.91[TSI][hapmap];0.87[EUR][1000 genomes] |
rs13072146 | 0.87[EUR][1000 genomes] |
rs13100110 | 0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs191714 | 0.81[CEU][hapmap] |
rs191775 | 0.81[CEU][hapmap] |
rs2881900 | 0.81[CEU][hapmap] |
rs28826701 | 0.83[AMR][1000 genomes];0.92[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs35514824 | 0.91[AMR][1000 genomes];0.95[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs361059 | 0.81[CEU][hapmap] |
rs361060 | 0.81[CEU][hapmap] |
rs361061 | 0.81[CEU][hapmap] |
rs361062 | 0.81[CEU][hapmap] |
rs361063 | 0.81[CEU][hapmap] |
rs361066 | 0.81[CEU][hapmap];0.82[MEX][hapmap] |
rs361067 | 0.81[CEU][hapmap] |
rs361071 | 0.81[CEU][hapmap] |
rs361072 | 0.81[CEU][hapmap] |
rs361080 | 0.81[CEU][hapmap] |
rs361082 | 0.81[CEU][hapmap] |
rs385254 | 0.81[CEU][hapmap] |
rs413147 | 0.81[CEU][hapmap];0.80[MEX][hapmap] |
rs4305444 | 0.81[CEU][hapmap] |
rs4894359 | 0.87[CEU][hapmap] |
rs497900 | 0.81[CEU][hapmap] |
rs500687 | 0.81[CEU][hapmap] |
rs524164 | 0.81[CEU][hapmap] |
rs558905 | 0.81[CEU][hapmap] |
rs564455 | 0.81[CEU][hapmap] |
rs62282204 | 0.85[EUR][1000 genomes] |
rs62282207 | 0.88[AMR][1000 genomes];0.97[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs6439828 | 0.96[CEU][hapmap];1.00[CHD][hapmap];0.89[TSI][hapmap];0.81[EUR][1000 genomes] |
rs6773514 | 0.85[CEU][hapmap] |
rs6776833 | 0.83[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs6784610 | 0.81[CEU][hapmap] |
rs7613579 | 0.85[CEU][hapmap];0.90[MEX][hapmap];0.80[TSI][hapmap];0.82[EUR][1000 genomes] |
rs7628172 | 0.83[EUR][1000 genomes] |
rs7634571 | 0.91[AMR][1000 genomes];0.99[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs7643722 | 0.81[CEU][hapmap];0.82[MEX][hapmap] |
rs7646689 | 0.83[EUR][1000 genomes] |
rs7650967 | 0.85[CEU][hapmap];0.81[MEX][hapmap];0.82[TSI][hapmap];0.83[EUR][1000 genomes] |
rs9289566 | 0.85[CEU][hapmap] |
rs9647336 | 0.81[CEU][hapmap] |
rs9647337 | 0.81[CEU][hapmap] |
rs9812318 | 0.94[AMR][1000 genomes];0.96[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs9813576 | 0.83[EUR][1000 genomes] |
rs9817727 | 0.83[EUR][1000 genomes] |
rs9817734 | 0.84[EUR][1000 genomes] |
rs9818521 | 0.81[ASN][1000 genomes] |
rs9821694 | 0.81[CEU][hapmap] |
rs9822500 | 0.81[EUR][1000 genomes] |
rs9822714 | 0.81[CEU][hapmap] |
rs9832447 | 0.84[EUR][1000 genomes] |
rs9834963 | 0.81[CEU][hapmap] |
rs9850990 | 0.82[EUR][1000 genomes] |
rs9851887 | 0.90[EUR][1000 genomes] |
rs9870355 | 0.89[AMR][1000 genomes];0.94[EUR][1000 genomes];0.94[ASN][1000 genomes] |
rs9871842 | 0.95[AMR][1000 genomes];1.00[EUR][1000 genomes];0.87[ASN][1000 genomes] |
rs9879784 | 0.81[CEU][hapmap] |
rs9881861 | 0.85[AMR][1000 genomes];0.91[EUR][1000 genomes];0.87[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv530057 | chr3:138014877-138734390 | Weak transcription Strong transcription Enhancers Active TSS ZNF genes & repeats Flanking Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
2 | nsv1013074 | chr3:138213166-138737688 | Strong transcription Enhancers Weak transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
3 | nsv1002612 | chr3:138213274-138831792 | Weak transcription Strong transcription Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Enhancers Genic enhancers Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
4 | nsv536726 | chr3:138213274-138831792 | Enhancers Flanking Active TSS Strong transcription Weak transcription ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 38 gene(s) | inside rSNPs | diseases |
5 | nsv1009726 | chr3:138219923-138737688 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Strong transcription ZNF genes & repeats Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 32 gene(s) | inside rSNPs | diseases |
6 | nsv869205 | chr3:138248190-138775288 | Enhancers Weak transcription Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 33 gene(s) | inside rSNPs | diseases |
7 | nsv868955 | chr3:138248190-138848947 | Bivalent Enhancer Bivalent/Poised TSS Strong transcription Flanking Active TSS Enhancers Weak transcription ZNF genes & repeats Flanking Bivalent TSS/Enh Active TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 37 gene(s) | inside rSNPs | diseases |
8 | nsv591854 | chr3:138348081-138764229 | Weak transcription Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers ZNF genes & repeats Strong transcription Active TSS Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 25 gene(s) | inside rSNPs | diseases |
9 | nsv1010514 | chr3:138365640-138737688 | Flanking Bivalent TSS/Enh Strong transcription Enhancers Weak transcription Active TSS Genic enhancers Bivalent Enhancer ZNF genes & repeats Flanking Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 23 gene(s) | inside rSNPs | diseases |
10 | nsv1000927 | chr3:138423543-138632596 | Genic enhancers Weak transcription Enhancers Strong transcription Active TSS Flanking Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
11 | nsv917964 | chr3:138440701-138699084 | Enhancers Bivalent Enhancer Active TSS ZNF genes & repeats Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Strong transcription Flanking Active TSS Genic enhancers Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 18 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:138595400-138600200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr3:138595400-138604600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
3 | chr3:138596400-138600000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr3:138596400-138600200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr3:138596600-138604200 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
6 | chr3:138598200-138600600 | Enhancers | Stomach Mucosa | stomach |
7 | chr3:138599000-138599800 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
8 | chr3:138599200-138600200 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
9 | chr3:138599200-138606000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |